Showing results (331-340 of 392) with videos related to

Sort By:
Pageof 40
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2025
COSMIC-021 Phase Ib Study of Cabozantinib Plus Atezolizumab: Results from the Locally Advanced or Metastatic Urothelial Carcinoma CohortsSumanta K Pal, Yohann Loriot, Andrea Necchi, et al.
Cancers|August 26, 2022
Psychosocial Aspects of Living Long Term with Advanced Cancer and Ongoing Systemic Treatment: A Scoping ReviewEvie E M Kolsteren, Esther Deuning-Smit, Alanna K Chu, et al.
The New England Journal of Medicine|October 26, 2007
Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancerJan B Vermorken, Eva Remenar, Carla van Herpen, et al.
Journal of Personalized Medicine|June 24, 2022
Genome-Wide Analyses of Nephrotoxicity in Platinum-Treated Cancer Patients Identify Association with Genetic Variant in RBMS3 and Acute Kidney InjuryMarije J Klumpers, Ward De Witte, Giovanna Gattuso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2009
Phase III study of gefitinib compared with intravenous methotrexate for recurrent squamous cell carcinoma of the head and neck [corrected]J Simon W Stewart, Ezra E W Cohen, Lisa Licitra, et al.
The Journal of Biological Chemistry|September 22, 2023
Myeloid-derived suppressor cells and tolerogenic dendritic cells are distinctively induced by PI3K and Wnt signaling pathwaysGlenn F van Wigcheren, Jorge Cuenca-Escalona, Suzan Stelloo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2011
Cancer patients treated with sunitinib or sorafenib have sufficient antibody and cellular immune responses to warrant influenza vaccinationSasja F Mulder, Joannes F M Jacobs, Michel A M Olde Nordkamp, et al.
Pageof 40